Patents
Sitemap › C07 - Organic chemistry › C07H - Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids › C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
11/1993
11/11/1993WO1993022424A1 RECOMBINANT STIMULATING FACTOR OF THE neu RECEPTOR
11/11/1993WO1993022342A1 Protein l and hybrid proteins thereof
11/11/1993WO1993022331A1 Human crabp-i and crabp-ii
11/11/1993WO1993022330A1 NUCLEIC ACID PROCESS PROBES TO $i(MYCOBACTERIUM TUBERCULOSIS)
11/11/1993WO1993022329A1 Methods and reagents for cleaving and deprotecting oligonucleotides
11/11/1993WO1993022326A1 Protecting groups useful in oligonucleotide synthesis
11/11/1993WO1993021959A1 Bystander effect tumoricidal therapy
11/11/1993WO1993021769A1 Diphtheria toxin receptor-binding region
11/11/1993WO1993020238A3 Amplification of human mdm2 gene in human tumors
11/11/1993WO1993018159A3 Compositions and methods for pace 4 and 4.1 gene and polypeptides in cells
11/11/1993CA2135052A1 Diphtheria toxin receptor-binding region
11/11/1993CA2134763A1 Bystander effect tumoricidal therapy
11/11/1993CA2134675A1 Development of a vector to target gene expression to the epidermis of transcenic animals
11/11/1993CA2134670A1 Constitutive and inducible epidermal vector systems
11/11/1993CA2134564A1 Recombinant stimulating factor of the neu receptor
11/11/1993CA2134550A1 Human crabp-i and crabp-ii
11/11/1993CA2134443A1 Inhibitory factor
11/11/1993CA2134337A1 Oligonucleotides and nucleic acids for detection of ureaplasma urealyticum
11/11/1993CA2130904A1 A predictive assay for suicidal behavior
11/10/1993EP0568622A1 CORTICOTROPIN RELEASING FACTOR BINDING PROTEIN (CRF-bp)
11/06/1993CA2067991A1 A thermostable ligase mediated dna amplification system for the detection of genetic diseases
11/03/1993EP0567841A2 Fluorescently marked compounds, their preparation and use
11/03/1993EP0567635A1 Rapid assays for amplification products
11/03/1993EP0505388A4 Improved one piece pouring spout sealed to innermost and outermost surfaces of moisture impervious carton
11/02/1993US5258538 For producing conjugates of organic moieties, such as fluorescent dyes and chromogens, and polymer supports or oligonucleotides
11/02/1993US5258507 Labeling reagents useful for the chemical attachment of nitrophenyl derivative ligands to DNA probes
11/02/1993US5258506 Photolabile reagents for incorporation into oligonucleotide chains
11/02/1993US5258369 Administering polynucleotides, cognition activators
11/02/1993US5258288 DNA sequences and genetic vectors
11/02/1993US5258287 DNA sequences and hybrids
10/1993
10/31/1993WO1993022260A1 Radiolabelled compound formulations
10/28/1993WO1993021344A1 Microwave modification of biological macromolecules
10/28/1993WO1993021318A1 Lymphocyte activation antigen hb15, a member of the immunoglobulin superfamily
10/28/1993WO1993021317A1 ISOLATION, CHARACTERIZATION, AND USE OF THE HUMAN β SUBUNIT OF THE HIGH AFFINITY RECEPTOR FOR IMMUNOGLOBULIN E
10/28/1993WO1993021316A1 Mammalian melanocyte stimulating hormone receptors and uses
10/28/1993WO1993021315A1 Mammalian adrenocorticotropic hormone receptors and uses
10/28/1993WO1993021314A1 Peptides having a gdp exchange factor activity, nucleic acid sequences coding for said peptides, preparation and utilization
10/28/1993WO1993021309A1 Oligonucleotide sequences and transgenic animals transfected therewith having reduced sensitivity to narcotic analgesics
10/28/1993WO1993021203A1 Synthesis of diverse and useful collections of oligonucleotides
10/28/1993WO1993021202A1 Synthetic antisense oligodeoxynucleotides and pharmaceutical compositions containing them
10/28/1993WO1993020694A1 Method and composition for inhibition of viral replication
10/28/1993CA2131166A1 Peptides having a gdp exchange factor activity, nucleic acid sequences coding for said peptides, preparation and utilization
10/28/1993CA2118249A1 Microwave modification of biological macromolecules
10/28/1993CA2117756A1 Oligonucleotide sequences and transgenic animals transfected therewith having reduced sensitivity to narcotic analgesics
10/27/1993EP0566751A1 DNA detection method
10/27/1993EP0222889B1 Cytidine analogs
10/26/1993US5256775 Exonuclease-resistant oligonucleotides
10/26/1993US5256648 Selective inhibition of gene expression by photoactivatable oligonucleotides
10/26/1993US5256549 Purification of synthetic oligomers
10/26/1993US5256535 Using rare earth chelate compound
10/26/1993CA1323592C Method of detecting nucleotide sequences
10/26/1993CA1323553C Method and device for improved restriction fragment length polymorphism analysis
10/20/1993EP0566158A1 The use of alpha-1-antitrypsin mutants in the manufacture of medicaments, and therapeutic formulations using mutants and their preparation
10/19/1993US5254469 Oligonucleotide-enzyme conjugate that can be used as a probe in hybridization assays and polymerase chain reaction procedures
10/14/1993WO1993020242A1 Encoded combinatorial chemical libraries
10/14/1993WO1993020240A1 Method and device for detection of nucleic acid or analyte using total internal reflectance
10/14/1993WO1993020238A2 Amplification of human mdm2 gene in human tumors
10/14/1993WO1993020235A1 Methods of detecting mammalian nucleic acids isolated from stool specimen and reagents therefor
10/14/1993WO1993020130A1 Apparatus for processing biopolymer-containing columns
10/14/1993WO1993020096A1 Oligonucleotide libraries useful for producing primers
10/14/1993WO1993020095A1 Antisense oligonucleotide inhibition of papillomavirus
10/14/1993WO1993020094A1 Haptens, tracers, immunogens and antibodies for quinoline
10/14/1993WO1993020093A1 Hybrid human/porcine factor viii
10/14/1993WO1993020092A1 Synthesis of oligonucleotides
10/14/1993WO1993020091A1 Support for oligonucleotide synthesis
10/14/1993WO1993020090A1 Paired-ion oligonucleotides and methods for preparing same
10/14/1993WO1993020074A1 Haptens, tracers, immunogens and antibodies for acridine-9-carboxylic acids
10/14/1993WO1993019605A1 Evaluation and treatment of patients with progressive immunosuppression
10/14/1993WO1993019591A1 Methods and compositions for gene, tumor, and viral infection therapy, and prevention of programmed cell death (apoptosis)
10/14/1993DE4211237A1 New 2',5'-oligo:adenylate 2',3'-cyclo-phosphate cpds. - useful for treating skin and mucosal lesions caused by papilloma viruses
10/14/1993CA2133643A1 Method and device for detection of nucleic acid or analyte using total internal reflectance
10/14/1993CA2132335A1 Delignifying preparation exhibiting .alpha.-l-arabinofuranosidase activity production and application thereof
10/14/1993CA2131994A1 Synthesis of oligonucleotides
10/14/1993CA2131993A1 Compounds
10/13/1993EP0564532A1 Polypeptides derived from proteins of the hepatitis c virus
10/13/1993EP0564524A1 Control of fruit ripening and senescence in plants
10/12/1993US5252760 Method of using colored phosphorylating reagents
10/12/1993US5252723 Method and reagent for sulfurization of organophosphorous compounds
10/12/1993US5252720 Metal complexes of water soluble texaphyrins
10/12/1993US5252296 Method and apparatus for biopolymer synthesis
10/06/1993EP0563287A1 Methods, kits and reactive supports for 3' labeling of oligonucleotides
10/05/1993CA1322745C Porous wafer for segmented synthesis of biopolymers
10/05/1993CA1322723C Inhibitors for replication of retroviruses and for the expression of oncogene products
09/1993
09/30/1993WO1993019206A1 Synthesis of fluorescence-labelled nucleic acids
09/30/1993WO1993019203A1 Oligonucleotide modulation of protein kinase c
09/30/1993WO1993019094A1 A monoclonal antibody to a human mdr1 multidrug resistance gene product, and uses
09/30/1993WO1993019090A1 High molecular weight surface proteines of non-typeable haemophilus
09/30/1993WO1993019079A1 Systemin
09/30/1993WO1993019078A1 Modified nucleotides
09/30/1993WO1993018759A1 A dna transporter system and method of use
09/30/1993WO1993016185A3 Biosynthetic binding protein for cancer marker
09/30/1993WO1993016094A3 Applications of fluorescent n-nucleosides and fluorescent structural analogs of n-nucleosides
09/30/1993CA2134237A1 In vivo peptide therapy
09/30/1993CA2132197A1 Systemin
09/30/1993CA2132094A1 Oligonucleotide modulation of protein kinase c
09/30/1993CA2131620A1 A dna transporter system and method of use
09/30/1993CA2117583A1 Modified nucleotides
09/30/1993CA2117582A1 Synthesis of fluorescence-labelled nucleic acids
09/29/1993EP0563010A2 Method of preparation of nucleosides
09/29/1993EP0562047A1 Sequencing by hybridization of a target nucleic acid to a matrix of defined oligonucleotides
1 ... 854 855 856 857 858 859 860 861 862 863 864 865 866 867 868 869 870 871 872 873 874 ... 899